62 results
Page 2 of 4
8-K
EX-10.3
54zwahv33
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.6
ykr4nun 27
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.2
frzyhxz
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.4
14lv8wx
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.1
4sbemoc8df7nzvl
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.7
mf5p7muk d1jui
7 Nov 22
Carve-out Condensed Consolidated Financial Statements
5:02pm
8-K
EX-10.1
26bp8darr89 b90l2
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.4
5jm9isb6t4hojix
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.2
2dp08ui6gthwwxbot
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.3
eemvp
2 Nov 22
Entry into a Material Definitive Agreement
8:31am
8-K
EX-10.1
h9k9h ih4l
27 Oct 22
Ignyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak Bio
8:30am
8-K
EX-10.1
cel1o5ksu3zhxfv
28 Sep 22
Regulation FD Disclosure
5:00pm
8-K
EX-10.1
bcdz n9vj65aytzva
20 Sep 22
Entry into a Material Definitive Agreement
9:42pm
8-K
EX-10.3
dwsfjlkbsq9069r1u
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.1
69h uto7l4f
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.2
634jdjbfpl75b
29 Apr 22
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
5:27pm
8-K
EX-10.1
p75jzz
25 Mar 22
Entry into a Material Definitive Agreement
4:15pm
10-K
EX-10.4
u6801ie6lvrl065e
15 Apr 21
Annual report
4:43pm
10-K
EX-10.1
ukn2m08esvwac
15 Apr 21
Annual report
4:43pm
10-K
EX-10.8
96o5obo8q3rhv
15 Apr 21
Annual report
4:43pm